
Carveford 3.125mg Tablet
Marketer
Leeford Healthcare Ltd
Salt Composition
Carvedilol (3.125mg)
Overview Carveford 3.125mg Tablet
CardiSol 3.125mg tablets effectively manage hypertension, angina pectoris, and congestive heart failure. Its mechanism involves vasodilation, facilitating improved cardiac blood flow. Reduced blood pressure contributes to a decreased risk of myocardial infarction and cerebrovascular accident. CardiSol 3.125mg tablets should be administered with meals, following your physician's prescribed dosage and schedule. Consistent use is crucial, even with symptom improvement or controlled blood pressure. Discontinuation requires medical consultation to prevent potential exacerbation of your condition. Lifestyle modifications, such as regular physical activity, weight management, smoking cessation, moderate alcohol consumption, and dietary sodium reduction (as directed by your doctor), enhance treatment efficacy. While generally well-tolerated, potential side effects include lightheadedness, cephalgia, dyspnea, and fatigue. Report persistent or bothersome side effects to your doctor. Prior to commencing treatment, disclose any pre-existing cardiac or renal conditions, and pregnant or lactating individuals should seek medical advice before using CardiSol 3.125mg tablets.
Uses of Carveford 3.125mg Tablet
Managing elevated blood pressure | Alleviating angina pectoris | Treating congestive heart failure
Major Benefits of Carveford 3.125mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 3.125mg Carveford tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Carveford 3.125mg Tablet:
- Decreased blood pressure
- Headache
- Fatigue
- Dizziness
- Breathlessness
How to use Carveford 3.125mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Carveford 3.125mg Tablet should be administered with a meal.
How Carveford 3.125mg Tablet works:
Carveford 3.125mg tablets combine alpha and beta-blocking actions. This dual mechanism reduces heart rate and dilates blood vessels, thereby improving the heart's pumping efficiency.
SAFETY ADVICE
AlcoholUNSAFE
Combining Carveford 3.125mg tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Carveford 3.125mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Seek medical advice before taking this medicine.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Carveford 3.125mg tablets without significant risk to their infants. Available human data indicates minimal infant exposure to the medication.
DrivingUNSAFE
Taking a Carveford 3.125mg tablet might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Carveford 3.125mg tablets may be used by patients with kidney disease without altering the prescribed dosage. Disclosure of pre-existing kidney conditions to your physician is advisable. Routine blood pressure monitoring is suggested to guide any necessary dosage modifications.
LiverCAUTION
Individuals with liver impairment should exercise caution when taking Carveford 3.125mg tablets; dosage modification may be necessary. Medical advice is recommended. Carveford 3.125mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Carveford 3.125mg Tablet :
Should you forget a Carveford 3.125mg Tablet dose, take it immediately if feasible. Otherwise, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Carveford 3.125mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Carbazole-propanol derivative |
| Developing Habits | No. |
| Treatment Category | Heart |
| Active Class | Alpha-blocker and beta-blocker combination |
